Literature DB >> 14588331

Conservative treatment for cervical spondylotic myelopathy. prediction of treatment effects by multivariate analysis.

H Yoshimatsu1, K Nagata, H Goto, K Sonoda, N Ando, H Imoto, T Mashima, Y Takamiya.   

Abstract

BACKGROUND CONTEXT: Many studies have suggested only slight effects of conservative treatment on cervical spondylotic myelopathy (CSM), whereas a few reports describe conservative treatment as being effective. This suggested the influence of various factors on treatment outcomes.
PURPOSE: We investigated symptomatic changes after conservative treatment in patients based on a clear understanding of the effects and limitations of conservative treatment. STUDY
DESIGN: We have encountered cases that showed symptomatic improvement with conservative treatment and became interested in the effectiveness of conservative treatment for CSM and whether other factors affect the results of conservative treatment. PATIENT SAMPLE: We have analyzed the results of conservative treatment for CSM in 69 cases, derived from a population of 101 CSM cases. OUTCOME MEASURES: Symptoms at the time of the first examination were compared with those at the final examination, and the patients were classified into three groups showing improvement, no change or exacerbation.
METHODS: Improvement or exacerbation of the symptoms was used as dependent variables and the collected factors as independent variables, and logistic regression was performed on these variables.
RESULTS: Multivariate analysis showed significant correlation between clinical outcome and the disease duration and the presence of rigorous conservative treatment.
CONCLUSIONS: Conservative treatment for CSM is considered to be effective if it is performed intensively in selected patients. In treating CSM, the therapeutic approach must be selected first in consideration of the patient's disease duration. Conservative treatment must be carried out intensively after sufficient explanation to the patients. Timely surgical intervention is considered to be important if the symptoms show no change or exacerbation with conservative treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 14588331     DOI: 10.1016/s1529-9430(01)00082-1

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  23 in total

Review 1.  [Spondylotic cervical myelopathy : Indication of surgical treatment].

Authors:  W Pepke; H Almansour; M Richter; M Akbar
Journal:  Orthopade       Date:  2018-06       Impact factor: 1.087

2.  Cervical cord compressive myelopathy in a man with a primary complaint of knee pain.

Authors:  Michael D Ross; Ryan Elliott
Journal:  J Spinal Cord Med       Date:  2010       Impact factor: 1.985

3.  Effectiveness of Riluzole as a pharmacotherapeutic treatment option for early cervical myelopathy: a double-blinded, placebo-controlled randomised controlled trial.

Authors:  S Rajasekaran; Siddharth N Aiyer; Ajoy Prasad Shetty; Rishi Mugesh Kanna; Anupama Maheswaran; Janardhan Yerram Shetty
Journal:  Eur Spine J       Date:  2015-11-23       Impact factor: 3.134

4.  Monitoring for myelopathic progression with multiparametric quantitative MRI.

Authors:  Allan R Martin; Benjamin De Leener; Julien Cohen-Adad; Sukhvinder Kalsi-Ryan; David W Cadotte; Jefferson R Wilson; Lindsay Tetreault; Aria Nouri; Adrian Crawley; David J Mikulis; Howard Ginsberg; Eric M Massicotte; Michael G Fehlings
Journal:  PLoS One       Date:  2018-04-17       Impact factor: 3.240

Review 5.  Change in Functional Impairment, Disability, and Quality of Life Following Operative Treatment for Degenerative Cervical Myelopathy: A Systematic Review and Meta-Analysis.

Authors:  Michael G Fehlings; Lindsay A Tetreault; Shekar Kurpad; Darrel S Brodke; Jefferson R Wilson; Justin S Smith; Paul M Arnold; Erika D Brodt; Joseph R Dettori
Journal:  Global Spine J       Date:  2017-09-05

Review 6.  Change in Function, Pain, and Quality of Life Following Structured Nonoperative Treatment in Patients With Degenerative Cervical Myelopathy: A Systematic Review.

Authors:  Lindsay A Tetreault; John Rhee; Heidi Prather; Brian K Kwon; Jefferson R Wilson; Allan R Martin; Ian B Andersson; Anna H Dembek; Krystle T Pagarigan; Joseph R Dettori; Michael G Fehlings
Journal:  Global Spine J       Date:  2017-09-05

7.  Evaluation of conservative treatment and timing of surgical intervention for mild forms of cervical spondylotic myelopathy.

Authors:  Ling-DE Kong; Ling-Chen Meng; Lin-Feng Wang; Yong Shen; Pan Wang; Zi-Kun Shang
Journal:  Exp Ther Med       Date:  2013-07-16       Impact factor: 2.447

8.  Cervical spinal canal stenosis and central disc herniation c3/4 in a man with primary complaint of thigh pain.

Authors:  R Akhavan-Sigari; V Rohde; A Alaid
Journal:  J Neurol Surg Rep       Date:  2013-07-12

9.  A Clinical Practice Guideline for the Management of Patients With Degenerative Cervical Myelopathy: Recommendations for Patients With Mild, Moderate, and Severe Disease and Nonmyelopathic Patients With Evidence of Cord Compression.

Authors:  Michael G Fehlings; Lindsay A Tetreault; K Daniel Riew; James W Middleton; Bizhan Aarabi; Paul M Arnold; Darrel S Brodke; Anthony S Burns; Simon Carette; Robert Chen; Kazuhiro Chiba; Joseph R Dettori; Julio C Furlan; James S Harrop; Langston T Holly; Sukhvinder Kalsi-Ryan; Mark Kotter; Brian K Kwon; Allan R Martin; James Milligan; Hiroaki Nakashima; Narihito Nagoshi; John Rhee; Anoushka Singh; Andrea C Skelly; Sumeet Sodhi; Jefferson R Wilson; Albert Yee; Jeffrey C Wang
Journal:  Global Spine J       Date:  2017-09-05

Review 10.  Current Diagnosis and Management of Cervical Spondylotic Myelopathy.

Authors:  Joshua Bakhsheshian; Vivek A Mehta; John C Liu
Journal:  Global Spine J       Date:  2017-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.